BioSpace News Archive

Berger Montague is investigating securities fraud claims against Inovio Pharmaceuticals, Inc. on behalf of all purchasers of Inovio common stock between February 14, 2020 and March 9, 2020..

CymaBay Therapeutics, Inc. confirmed that Engine Capital Management has nominated three candidates to stand for election to the Company’s Board of Directors at the 2020 Annual Meeting.

ACS-IL Responds Quickly to President Trump’s News Conference Declaring National Emergency

With coronavirus case counts climbing, New Jersey hospitals and the New Jersey Hospital Association are moving to enact no-visitor policies to protect patients, visitors and staff.

On March 11 th , The World Health Organization (WHO) declared a pandemic. Additionally, President Donald Trump declared the pandemic a national emergency. Over the last few days, GOJO Industries has experienced a dramatic increase in orders of PURELL ®

Approximately 100,000 U.S. Medical Visits in Seven Days Expand Capacity of Stretched Health Care System

Genetic Technologies Limited announced that after the close of the ASX market on March 13, 2020, it received a determination letter from The Nasdaq Stock Market LLC indicating that it did not comply with the Listing Rule 5550 for continued listing on the Nasdaq Capital Market

The U.S. Food and Drug Administration took another significant diagnostic action during the coronavirus outbreak.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-Co

BD, issued the following statement after a White House meeting with CEOs of companies who have been involved in the effort to expand access to COVID-19 testing and test development.